Dr. Reddy's Laboratories Limited
RDY
$13.03
-$0.23-1.74%
NYSE
| 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | |
|---|---|---|---|---|---|
| Net Income | 23.27M | 135.83M | 164.61M | 165.68M | 184.13M |
| Total Depreciation and Amortization | 58.96M | 58.52M | 57.86M | 55.68M | 52.61M |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 6.67M | 19.32M | -14.81M | 45.31M | 10.63M |
| Change in Net Operating Assets | 76.52M | -91.22M | -29.28M | -95.72M | 6.75M |
| Cash from Operations | 165.42M | 122.45M | 178.38M | 170.95M | 254.12M |
| Capital Expenditure | -47.98M | -75.26M | -59.83M | -80.17M | -88.52M |
| Sale of Property, Plant, and Equipment | 1.66M | 112.30K | 1.26M | 373.90K | -115.50K |
| Cash Acquisitions | -33.33M | -- | -- | -- | -19.12M |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -200.40M | -40.39M | -50.74M | -144.47M | -45.90M |
| Cash from Investing | -280.05M | -115.53M | -109.31M | -224.27M | -153.66M |
| Total Debt Issued | 8.61B | 8.97B | 2.61B | 70.00M | -4.89B |
| Total Debt Repaid | -411.00M | -288.00M | -239.00M | -326.00M | -253.00M |
| Issuance of Common Stock | 79.00M | 30.00M | 92.00M | 196.00M | 11.00M |
| Repurchase of Common Stock | -- | -- | -- | -- | -1.39B |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | 0.00 | 0.00 | -76.27M | -- | 0.00 |
| Other Financing Activities | -1.24B | -936.00M | -1.12B | -1.14B | -846.00M |
| Cash from Financing | 74.43M | 87.30M | -60.97M | -14.06M | -85.15M |
| Foreign Exchange rate Adjustments | 5.42M | 4.02M | 2.23M | 2.07M | 2.72M |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -34.78M | 98.24M | 10.33M | -65.31M | 18.03M |